Anti-Covid Pill Soon As Drug Regulator Approves Emergency Use
NDTV
Earlier this year, these companies had signed non-exclusive voluntary licensing agreements with MSD to manufacture and supply the generic version of Molnupiravir in over 100 low and middle-income countries (LMICs), including India.
With the DCGI approving the anti-COVID-19 pill Molnupiravir for emergency use in the country, Strides Pharma on Tuesday said it will launch the capsule immediately while six other homegrown pharma companies announced rolling out their generic versions of the drug shortly.
Strides, Dr Reddy's, Sun Pharma, Cipla, Hetero, Torrent and Optimus said they have received approvals from the Drugs Controller General of India (DCGI) to manufacture and market their versions of Molnupiravir, an oral medication for COVID-19, for restricted use in emergency situation (EUA) in India.
They plan to market the capsules under their respective brands and make them available at all leading pharmacies and COVID-treatment centres across the country.
Earlier this year, these companies had signed non-exclusive voluntary licensing agreements with MSD to manufacture and supply the generic version of Molnupiravir in over 100 low and middle-income countries (LMICs), including India.
